Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Assessment of an scFv Antibody Fragment Against ELTD1 in a G55 Glioblastoma Xenograft Model

Translational Oncology(2020)10.1016/j.tranon.2019.12.009Source: DataRank Database

Assessment of an scFv Antibody Fragment Against ELTD1 in a G55 Glioblastoma Xenograft Model is a research paper published in Translational Oncology (2020). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 1.35)OA: goldTopics (29)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Nataliya Smith,Debra Saunders,Tanvi Saran,Lincy Thomas,Rafał Gulej ORCID

Live enrichment

PubMed:32208341 PMC:PMC7090355 OpenAlex:https://openalex.org/W3012892933

NIGMS NIH HHS

Grant: P20 GM103639

NIH HHS

Grant: S10 OD023508

NCI NIH HHS

Grant: P30 CA225520

National Institutes of Health

Grant: 5P20GM103639-08

Mentoring Translational Cancer Research in Oklahoma

National Institutes of Health

Grant: 1S10OD023508-01

Pre-Clinical 7T MRI for Oklahoma

National Institutes of Health

Grant: 5P20GM103639-03

TUMOR RESISTANCE MECHANISMS TO ANTI-VEGF THERAPY IN PROSTATE CANCER (Sukyung Woo)

National Institutes of Health

Grant: 3P30CA225520-03S2

Stephenson Cancer Center - Cancer Center Support Grant

National Institutes of Health

Grant: 3P30CA225520-06S4

Stephenson Cancer Center - Cancer Center Support Grant

National Institutes of Health

Oklahoma Medical Research Foundation

FWCI

1.35

Citation Percentile

0.8%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.tranon.2019.12.009

publisherhttps://doi.org/10.1016/j.tranon.2019.12.009

publisherhttps://api.elsevier.com/content/article/PII:S1936523319305297?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1936523319305297?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32208341

Fields of Study

Glioma Diagnosis and TreatmentMicrotubule and mitosis dynamicsAdvanced Electron Microscopy Techniques and Applications0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

GliomaAntibodyAngiogenesisPathologyMedicineCancer researchBrain tumorMonoclonal antibodyImmunohistochemistryGlioblastomaPerfusionIn vivoBiologyImmunologyInternal medicineMRIGlioblastoma (Gbm)Single Chain Variable Fragment (Scfv)Eltd1Orthotopic G55 Xenograft ModelOriginal articleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being